4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Anixa Biosciences, Inc. (ANIX) operates in the Biotechnology industry and is headquartered in San Jose, United States with about 4 employees. Its market capitalization is roughly $128 million. In the fiscal year ended 2025-10-31, ANIX reported $0M in revenue and ($11M) in net income.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
Interactive charts & full statements →
| Income statement | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($12M) | ($14M) | ($11M) | ($14M) | — |
| Net Income | ($11M) | ($13M) | ($10M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — | — |
| Gross Profit | — | — | — | — | — | — | $0M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($3M) | ($2M) | ($3M) | — | — |
| Net Income | ($2M) | ($3M) | ($3M) | ($2M) | ($3M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Total Assets | $16M | $22M | $26M | $30M | — |
| Total Liabilities | $2M | $3M | $2M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANIX viewer.
About TickerBase · Data methodology & sources